Fig. 6From: The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s diseaseSYNJ1 is co-enriched with PHF-tau in sarkosyl-insoluble fraction. a WB for SYNJ1 and PHF1 in sarkosyl-insoluble fraction of control (n = 3) and AD (SAD n = 3, FAD with APP mutation n = 1). SYNJ1 was enriched in sarkosyl-insoluble fractions with PHF-tau. b Representative image of the sarkosyl-insoluble PHF-tau of a sporadic AD case taken by transmission electron microscopy. Scale bar 0.2 μmBack to article page